108 related articles for article (PubMed ID: 2744035)
21. Diminished peripheral blood monocyte DR antigen expression in systemic lupus erythematosus.
Nagai H; Sztein MB; Steeg PS; Hooks JJ; Oppenheim JJ; Steinberg AD
Clin Exp Rheumatol; 1984; 2(2):131-7. PubMed ID: 6598101
[TBL] [Abstract][Full Text] [Related]
22. Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration.
Kalsi JK; Grossman J; Kim J; Sieling P; Gjertson DW; Reed EF; Ebling FM; Linker-Israeli M; Hahn BH
Lupus; 2004; 13(7):490-500. PubMed ID: 15352419
[TBL] [Abstract][Full Text] [Related]
23. 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
Tsuchiya N; Mitamura T; Goto M; Moroi Y; Kinoshita M; Yokohari R; Miyamoto T
J Rheumatol; 1988 Jun; 15(6):946-51. PubMed ID: 3262161
[TBL] [Abstract][Full Text] [Related]
24. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway.
Rupasree Y; Naushad SM; Rajasekhar L; Kutala VK
Gene; 2014 Feb; 536(1):45-52. PubMed ID: 24333266
[TBL] [Abstract][Full Text] [Related]
26. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
[TBL] [Abstract][Full Text] [Related]
27. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.
Niu Z; Zhang P; Tong Y
Int J Rheum Dis; 2015 Jan; 18(1):17-28. PubMed ID: 25546242
[TBL] [Abstract][Full Text] [Related]
28. Subsets of activated T cells in patients with systemic lupus erythematosus: the relation to cell cycle.
Tokano Y; Morimoto S; Hishikawa T; Murashima A; Abe M; Sekigawa I; Takasaki Y; Hashimoto H; Okumura K; Shirai T; Hirose S
Scand J Rheumatol; 1997; 26(1):37-42. PubMed ID: 9057800
[TBL] [Abstract][Full Text] [Related]
29. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.
Inghirami G; Simon J; Balow JE; Tsokos GC
Clin Exp Rheumatol; 1988; 6(3):269-76. PubMed ID: 3263240
[TBL] [Abstract][Full Text] [Related]
30. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
Spronk PE; vd Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1993 Jul; 93(1):39-44. PubMed ID: 8100746
[TBL] [Abstract][Full Text] [Related]
31. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
[TBL] [Abstract][Full Text] [Related]
32. (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus.
Shalev Y; Bentwich Z; Katz D; Brautbar C; Mozes E
Clin Exp Immunol; 1985 May; 60(2):355-62. PubMed ID: 2408803
[TBL] [Abstract][Full Text] [Related]
33. [Association of HLA-A, B, and DR haplotypes with genotype in Chinese children with systemic lupus erythematosus].
Li CF; He XH; Teng Q; Jiang ZF
Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):422-5. PubMed ID: 14748996
[TBL] [Abstract][Full Text] [Related]
34. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
35. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus.
Jacobi AM; Mei H; Hoyer BF; Mumtaz IM; Thiele K; Radbruch A; Burmester GR; Hiepe F; Dörner T
Ann Rheum Dis; 2010 Jan; 69(1):305-8. PubMed ID: 19196727
[TBL] [Abstract][Full Text] [Related]
37. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients.
Savi M; Ferraccioli GF; Neri TM; Zanelli P; Dall'Aglio PP; Tincani A; Balestrieri G; Carella G; Cattaneo R
Arthritis Rheum; 1988 Dec; 31(12):1568-70. PubMed ID: 3196369
[TBL] [Abstract][Full Text] [Related]
39. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
Burbano C; Vasquez G; Rojas M
Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
[TBL] [Abstract][Full Text] [Related]
40. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
